Merck & Co., Inc. is 150.2x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($294.03 B vs $1.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | MRK |
|---|---|---|
| Market cap | $1.96 B | $294.03 B |
| US-listed rank | #2127 | #45 |
| Revenue (latest FY) | $51.95M | $65.01B |
| Net income (latest FY) | -$265.94M | $18.25B |
| Net margin | -511.9% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 827 | 996 |
Merck & Co., Inc. is 150.2x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($294.03 B vs $1.96 B).
In their latest fiscal years, OCULAR THERAPEUTIX, INC reported $51.95M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: OCULAR THERAPEUTIX, INC and Merck & Co., Inc., or browse the full rankings.